Strengthening HIV Testing and Surveillance from Bench to Bedside
Thermo Fisher Scientific
Resources offering guidance on HIV drug resistance, testing strategies, and surveillance
HIV diagnosis
Break the Cycle of Untreated Syphilis with Rapid Testing
Today's Clinical Lab
Transform care in high-incidence settings with a 10-minute test that delivers same-visit treatment and better outcomes
The Impact of Emerging Dolutegravir Resistance on Global HIV Treatment and Prevention
Today's Clinical Lab, Thermo Fisher Scientific
Dr. Obiageli Okafor discusses growing resistance to dolutegravir and the need for global access to affordable HIV treatment and prevention
Building an Affordable and Immunogenic HIV Vaccine
Amsterdam University Medical Centers
This global project aims to discover an HIV vaccine that is practical for those in low-resource countries
Cisgender Women Excluded in Pivotal STI Prevention Studies
National Institutes of Health
NIH leadership calls for population-specific considerations in study design
Targeting Viral Protein May Reduce HIV-Related Comorbidities
University of Montreal Hospital Research Centre
Per the WHO records, more than 39 million people were living with HIV at the end of 2022
Remote Testing May Keep US STI Crisis under Check
Preventx
At-home or remote testing approach may free up healthcare workers, boost reach and accessibility
WHO Drafts Guideline on Inclusive Health for Trans, Gender-Diverse People
World Health Organization
The guideline will be examined and reviewed by a development group in late 2023
HIV Declines among Young People, New Infections Drop
Centers for Disease Control and Prevention
Increased investments, innovation, and focus on equity are vitally needed to end the HIV epidemic
FDA Approves New HIV Drug for Adults with Limited Treatment Options
U.S. Food and Drug Administration
The new medication is for those whose HIV infections cannot be successfully treated with other treatments